Synthesis, structure–activity relationships and biological evaluation of barbigerone analogues as anti-proliferative and anti-angiogenesis agents-Reference-Cited by-同舟云学术

Synthesis, structure–activity relationships and biological evaluation of barbigerone analogues as anti-proliferative and anti-angiogenesis agents

Published:2014-07 Issue:14 Volume:24 Page:3158-3163
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Wang Guangcheng,Wang Fang,Cao Dong,Liu Yibin,Zhang Ronghong,Ye Haoyu,Li Xiuxia,He Lin,Yang Zhuang,Ma Liang,Peng Aihua,Xiang Mingli,Wei Yuquan,Chen Lijuan

Funder

National Key Programs of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference27 articles.

1. Angiogenesis in cancer, vascular, rheumatoid and other disease

2. Angiogenesis as a therapeutic target

3. Angiogenesis: an organizing principle for drug discovery?

4. Therapeutic options to target angiogenesis in human malignancies

5. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure–Activity Relationship Prediction‐Based Synthesis and Cytotoxicity Evaluation against the HEp‐2 Laryngeal Carcinoma Cell of Isoflavone–Cytisine Mannich Bases;Chemistry & Biodiversity;2023-08

2. The Suzuki-Miyaura Cross-Coupling-Claisen Rearrangement-Cross-Metathesis Approach to Prenylated Isoflavones;J ORG CHEM;2023

3. The Suzuki–Miyaura Cross-Coupling–Claisen Rearrangement–Cross-Metathesis Approach to Prenylated Isoflavones;The Journal of Organic Chemistry;2023-01-12

4. Crystal structure of tubulin-barbigerone complex enables rational design of potent anticancer agents with isoflavone skeleton;Phytomedicine;2023-01

5. Recent advances in the synthesis of 4H-chromen-4-ones (2012 − 2021);Advances in Heterocyclic Chemistry;2022